| ID | Age | Sex | State | Date โผ | Onset Days | Vaccine | Manufacturer | Lot # | Symptoms | Narrative | ๐ | ๐ฅ | ๐ | โฟ | โ ๏ธ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2831562 | 65 | M | UT | 03/14/2025 |
PNC20 |
PFIZER\WYETH |
LP8151 |
Cough, Throat irritation
Cough, Throat irritation
|
Tickle in throat and slight cough.
Tickle in throat and slight cough.
|
||||||
| 2831563 | 16 | M | GA | 03/14/2025 |
COVID19 |
PFIZER\BIONTECH |
LM2212 |
Rash, Rash erythematous, Skin exfoliation, Streptococcus test negative, Tenderne...
Rash, Rash erythematous, Skin exfoliation, Streptococcus test negative, Tenderness
More
|
WITHIN A DAY AND A HALF OF RECEIVING COVID VACCINE, PATIENT'S PALMS HAD RED BUMPS APPEAR. PALMS...
WITHIN A DAY AND A HALF OF RECEIVING COVID VACCINE, PATIENT'S PALMS HAD RED BUMPS APPEAR. PALMS CONTINUED TO GET RED AND THEN STARTED TO HURT. WITHIN A COUPLE MORE DAYS THE PALMS BEGAN TO PEEL AND BECOME TENDER. PATIENT WENT TO PROVIDER AND WAS TESTED FOR STREP BUT WAS NEGATIVE. THE PHYSICIAN AND PATIENT ARE THINKING IT IS IN RESPONSE TO THE COVID VACCINE.
More
|
||||||
| 2831564 | 62 | F | KS | 03/14/2025 |
PNC21 VARZOS |
MERCK & CO. INC. GLAXOSMITHKLINE BIOLOGICALS |
Y013009 N77J2 |
Headache, Pruritus, Pyrexia; Headache, Pruritus, Pyrexia
Headache, Pruritus, Pyrexia; Headache, Pruritus, Pyrexia
|
Patient experienced headache, itching, and mild fever. Recommended Ibuprofen or Aleve OTC. Patient t...
Patient experienced headache, itching, and mild fever. Recommended Ibuprofen or Aleve OTC. Patient to report to doctor if symptoms persist after two days.
More
|
||||||
| 2831565 | 77 | F | FL | 03/14/2025 |
PNC21 |
MERCK & CO. INC. |
Y019158 |
Injection site erythema
Injection site erythema
|
Patient came to pharmacy 3/14 and reported after getting her vaccine she developed a red spot on the...
Patient came to pharmacy 3/14 and reported after getting her vaccine she developed a red spot on the injection site and another about 2 inches below the injection site.
More
|
||||||
| 2831573 | 2 | M | CA | 03/14/2025 |
DTAP |
GLAXOSMITHKLINE BIOLOGICALS |
Y97N7 |
Inappropriate schedule of product administration, No adverse event
Inappropriate schedule of product administration, No adverse event
|
Vaccine is considered not 'NOT VALID" next dose due until age 4 years. No symptoms relat...
Vaccine is considered not 'NOT VALID" next dose due until age 4 years. No symptoms related to Vaccine.
More
|
||||||
| 2831574 | 68 | F | 03/14/2025 |
VARZOS VARZOS |
GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS |
|
Arthralgia, Eye swelling, Injection site erythema, Injection site pain, Malaise;...
Arthralgia, Eye swelling, Injection site erythema, Injection site pain, Malaise; Myalgia
More
|
Day after vaccine: malaise, joint and muscle pain, redness and soreness at injection site. 2nd day p...
Day after vaccine: malaise, joint and muscle pain, redness and soreness at injection site. 2nd day post injection: both eyes swollen, continued redness and soreness at injection site.
More
|
|||||||
| 2831575 | 39 | F | CA | 03/14/2025 |
TDAP |
GLAXOSMITHKLINE BIOLOGICALS |
39LB7 |
Extra dose administered, No adverse event
Extra dose administered, No adverse event
|
Double vaccine dose was given to patient. Patient report no symptoms.
Double vaccine dose was given to patient. Patient report no symptoms.
|
||||||
| 2831576 | 50 | F | TN | 03/14/2025 |
VARZOS |
GLAXOSMITHKLINE BIOLOGICALS |
29Z52 |
Rash, Rash pruritic
Rash, Rash pruritic
|
The patient stopped by clinic on 03/14/2025 inquiring if she should get dose 2, reports that days af...
The patient stopped by clinic on 03/14/2025 inquiring if she should get dose 2, reports that days after getting dose 1 developed a very itchy rash to both arms and chest and had to take benadryl as well as seek care at an outside facility and was prescribed steroids.
More
|
||||||
| 2831577 | 53 | M | OR | 03/14/2025 |
UNK |
UNKNOWN MANUFACTURER |
Y018157 |
Product administered to patient of inappropriate age
Product administered to patient of inappropriate age
|
none
none
|
||||||
| 2831578 | 45 | F | AZ | 03/14/2025 |
HEP |
GLAXOSMITHKLINE BIOLOGICALS |
AZ453 |
Fatigue, Hypoaesthesia, Injection site pain, Paraesthesia
Fatigue, Hypoaesthesia, Injection site pain, Paraesthesia
|
Pt presented to clinic to report since she received the hep b and flu shot on 3/12/25 at clinic, she...
Pt presented to clinic to report since she received the hep b and flu shot on 3/12/25 at clinic, she states yesterday 3/13/25 and today 3/14/25 she experienced numbness and " pins and needles sensation" tingling on left leg back hamstring/ left hip and top of left foot. She stated the vaccines were given in her left arm deltoid muscle. She has experienced fatigue and soreness at injection site. I re-assured her that fatigue and soreness are to be expected after vaccines and it would be ok to take OTC tylenol or ibuprofen for soreness at injection site if needed. She was able to ambulate from waiting room and getting up from a sitting position to a standing postion with no assistance or visible deficit. Spoke to our provider, he advised for pt to watch for any worsening symptoms and to go to ER or urgent care if symptoms persist or worsen. Also instructed pt to notify her PCP today of her symptoms of numbness/tingling, fatigue. Pt verbalized understanding. Vaers report completed. Notified Dr. at County Health Dept of situation, he advised for pt to follow up with PCP and if symptoms worsen or persist to go to urgent care/ ER to be evaluated.
More
|
||||||
| 2831579 | 26 | F | TX | 03/14/2025 |
HPV9 TDAP |
MERCK & CO. INC. GLAXOSMITHKLINE BIOLOGICALS |
Y010466 7KD5B |
Syncope; Syncope
Syncope; Syncope
|
Vasovagal syncope
Vasovagal syncope
|
||||||
| 2831040 | 03/13/2025 |
COVID19 |
JANSSEN |
|
Adverse event, Injury
Adverse event, Injury
|
side effects for 4 years; injury; This spontaneous report received from a patient concerned a patien...
side effects for 4 years; injury; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height and weight were not reported. Age at time of vaccination was unknown. No past medical history, concurrent conditions or pre-existing medical conditions were reported. The patient received janssen covid-19 vaccine (suspension for injection, intramuscular, batch number not reported) dose, frequency and therapy dates not reported, additional dosage information included: dose series 1, for covid-19 prophylaxis. The batch number was not reported. Company was unable to perform follow up to request batch/lot number. No concomitant medications were reported. On an unspecified date, the patient experienced side effects for 4 years and injury. (dose series 1) The patient took C19 Vaccine and have had all sorts of side effects for 4 years and was looking for help. The action taken with janssen covid-19 vaccine was not applicable. The outcome of side effects for 4 years and injury was not reported. This report was serious (disability/permanent damage).; Sender's Comments: V0-Adverse event, Injury. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event. Therefore, the WHO Causality is considered indeterminate. The company causality is considered unassessable.
More
|
โ | ||||||||
| 2831054 | 03/13/2025 |
MMR |
GLAXOSMITHKLINE BIOLOGICALS |
43G92 |
Febrile convulsion
Febrile convulsion
|
Febrile seizures; This serious case was reported by a pharmacist via sales rep and described the occ...
Febrile seizures; This serious case was reported by a pharmacist via sales rep and described the occurrence of febrile seizure in a 1-year-old patient who received MMR (Priorix) (batch number 43G92) for prophylaxis. On 06-MAR-2025, the patient received the 1st dose of Priorix. In MAR-2025, an unknown time after receiving Priorix, the patient experienced febrile seizure (Verbatim: Febrile seizures) (serious criteria hospitalization and GSK medically significant). The outcome of the febrile seizure was resolving. The reporter considered the febrile seizure to be related to Priorix and Priorix Pre-Filled Syringe Device. The company considered the febrile seizure to be unrelated to Priorix and Priorix Pre-Filled Syringe Device. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 07-MAR-2025 The patient received a first dose of Priorix and experienced febrile seizure after vaccination. The patient required hospitalization and rapid response.; Sender's Comments: Febrile convulsion is a listed event which, due to the following criteria (insufficient information regarding medical history, concurrent conditions, concomitant medications, time to onset, confirmation of disease) is considered unrelated to GSK vaccine Priorix and Priorix PRE-FILLED SYRINGE DEVICE.
More
|
โ | ||||||||
| 2831055 | F | 03/13/2025 |
VARZOS |
UNKNOWN MANUFACTURER |
UNK |
Herpes zoster, Irritability, Pain, Pruritus, Vaccination failure
Herpes zoster, Irritability, Pain, Pruritus, Vaccination failure
|
Suspected Vaccination failure; shingles; This serious case was reported by a consumer via interactiv...
Suspected Vaccination failure; shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a elderly female patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. In JUL-2024, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Suspected Vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: shingles). The outcome of the vaccination failure and shingles were not reported. The reporter considered the vaccination failure and shingles to be related to Shingles vaccine. The company considered the vaccination failure and shingles to be unrelated to Shingles vaccine. Additional Information: GSK Receipt Date: 01-MAR-2025 This case was reported by a patient via interactive digital media. They had the shingle vaccination 2 years ago, just got shingles 80 in July 2024 hurt, itch and irritable. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting.; Sender's Comments: Herpes zoster is an unlisted event which is considered unrelated to GSK Shingles vaccine. Vaccination failure is a listed event which, due to the following criteria (insufficient information provided about the clinical description, details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of disease) is considered unrelated to GSK Shingles vaccine.
More
|
||||||||
| 2831056 | F | 03/13/2025 |
VARZOS |
GLAXOSMITHKLINE BIOLOGICALS |
UNK |
Herpes zoster, Pain, Vaccination failure
Herpes zoster, Pain, Vaccination failure
|
Suspected vaccination failure; had shingles 3 times; This serious case was reported by a consumer vi...
Suspected vaccination failure; had shingles 3 times; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced vaccination failure (Verbatim: Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: had shingles 3 times). The outcome of the vaccination failure and shingles were not reported. The reporter considered the vaccination failure and shingles to be related to Shingrix. The company considered the vaccination failure and shingles to be unrelated to Shingrix. Additional Information: GSK Receipt Date: 08-MAR-2025 The case was received from the patient via (Instagram) interactive digital media. The reporter reported that you were the best person to encourage anyone, he/she had shingles 3 times unfortunately the vaccine did not work but he/she would not want anyone to suffer it's undescribable pain. This case was considered as suspected vaccination failure as details regarding completion of primary schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting.; Sender's Comments: Herpes zoster is an unlisted event which is considered unrelated to GSK vaccine Shingrix. Vaccination failure is a listed event which, due to the following criteria (insufficient information provided about the clinical description, details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of disease) is considered unrelated to GSK vaccine Shingrix.
More
|
||||||||
| 2831057 | F | 03/13/2025 |
VARZOS |
GLAXOSMITHKLINE BIOLOGICALS |
UNK |
Herpes zoster, Pain, Vaccination failure
Herpes zoster, Pain, Vaccination failure
|
suspected vaccination failure; had the shot and still got them they were on back and under skin very...
suspected vaccination failure; had the shot and still got them they were on back and under skin very painful; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced vaccination failure (Verbatim: suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: had the shot and still got them they were on back and under skin very painful). The outcome of the vaccination failure and shingles were not reported. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingrix. The company considered the vaccination failure and shingles to be unrelated to Shingrix. Additional Information: GSK Receipt Date: 08-MAR-2025 This case was reported by a patient via interactive digital media. The patient had Shingrix shot and still got shingles on back and under skin, it was very painful. This case was considered as suspected vaccination failure as details regarding completion of primary schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting.; Sender's Comments: Herpes zoster is an unlisted event which is considered unrelated to GSK vaccine Shingrix. Vaccination failure is a listed event which, due to the following criteria (insufficient information provided about the clinical description, details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of disease) is considered unrelated to GSK vaccine Shingrix.
More
|
||||||||
| 2831058 | 03/13/2025 |
VARZOS |
UNKNOWN MANUFACTURER |
UNK |
Herpes zoster, Vaccination failure
Herpes zoster, Vaccination failure
|
suspected vaccination failure; shingles; This serious case was reported by a consumer via interactiv...
suspected vaccination failure; shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: shingles). The outcome of the vaccination failure was not reported and the outcome of the shingles was not resolved. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. The company considered the vaccination failure to be unrelated to Shingles vaccine. It was unknown if the company considered the shingles to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 07-MAR-2025 This case was reported by a patient via interactive digital media. Patient had the vaccine and got shingles and stated that they were excruciating. The patient stated that one in three would get shingles. Also stated that it was day 10 they were long way from recovery. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting.; Sender's Comments: Vaccination failure is a listed event which, due to the following criteria (insufficient information provided about the clinical description, details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of disease) is considered unrelated to GSK Shingles vaccine.
More
|
|||||||||
| 2831059 | 03/13/2025 |
VARZOS |
UNKNOWN MANUFACTURER |
UNK |
Herpes zoster, Vaccination failure
Herpes zoster, Vaccination failure
|
Suspected vaccination failure; Ending Up Getting It; This serious case was reported by a consumer vi...
Suspected vaccination failure; Ending Up Getting It; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Suspected vaccination failure) (serious criteria hospitalization and GSK medically significant) and shingles (Verbatim: Ending Up Getting It) (serious criteria hospitalization). The outcome of the vaccination failure and shingles were not reported. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. The company considered the vaccination failure and shingles to be unrelated to Shingles vaccine. Additional Information: GSK Receipt Date: 09-MAR-2025 The case was received from the patient via interactive digital media. The patient got the shingle shot and ending up getting it. The patient was in the hospital. This case was considered as suspected vaccination failure as details regarding completion of primary schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting.; Sender's Comments: Vaccination failure is a listed event which, due to the following criteria (insufficient information provided about the clinical description, details regarding the completion of primary vaccination schedule, time to onset and laboratory confirmation of disease) is considered unrelated to GSK Shingles vaccine. Herpes zoster is an unlisted event which is considered unrelated to GSK Shingles vaccine.
More
|
โ | ||||||||
| 2831060 | F | MO | 03/13/2025 |
DTAPIPV |
GLAXOSMITHKLINE BIOLOGICALS |
3RT93 |
Product administered to patient of inappropriate age, Wrong product administered
Product administered to patient of inappropriate age, Wrong product administered
|
maladministration of Kinrix instead of Pediarix dose; Maladministration of Kinrix on a pediatric pat...
maladministration of Kinrix instead of Pediarix dose; Maladministration of Kinrix on a pediatric patient-underage; This non-serious case was reported by a other health professional via call center representative and described the occurrence of wrong vaccine administered in a 4-month-old female patient who received DTPa-IPV (Kinrix) (batch number 3RT93, expiry date 03-APR-2026) for prophylaxis. Co-suspect products included DTPa-HBV-IPV (Pediarix) for prophylaxis. On an unknown date, the patient received Kinrix and Pediarix. On an unknown date, an unknown time after receiving Kinrix and not applicable after receiving Pediarix, the patient experienced wrong vaccine administered (Verbatim: maladministration of Kinrix instead of Pediarix dose) and inappropriate age at vaccine administration (Verbatim: Maladministration of Kinrix on a pediatric patient-underage). The outcome of the wrong vaccine administered and inappropriate age at vaccine administration were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date : 03-MAR-2025 Medical Assistant called to reported that the maladministration of Kinrix instead of Pediarix (pediatric patient, underage), which led to wrong vaccine administered and inappropriate age at vaccine administration. Vaccine detail and patient demographics were obtained from the reporter๏ฟฝs end. The vaccine administration facility was the same as primary reporter. No further information was obtained in this call.
More
|
|||||||
| 2831061 | 0.17 | M | CA | 03/13/2025 |
DTAPIPVHIB |
SANOFI PASTEUR |
UK110AA |
No adverse event, Product preparation issue
No adverse event, Product preparation issue
|
hib component was not reconstituted with the Dtap-IPV component of PENTACEL, with no reported advers...
hib component was not reconstituted with the Dtap-IPV component of PENTACEL, with no reported adverse event; Initial information received on 10-Mar-2025 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 2 months old male patient and reporter reported that the HIB component was not reconstituted with the DTAP-IVP component of Diphtheria/Tetanus/5 Hybrid AC Pertussis/IPV(Vero)/HIB(PRP/T) Vaccine [Pentacel] with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included Rotavirus Vaccine; Pneumococcal Vaccine Conj 15v (Crm197) And Hepatitis B vaccine for Immunisation. On 07-Mar-2025, the patient received a HIB component was not reconstituted with the DTAP-IVP component of Diphtheria/Tetanus/5 Hybrid AC Pertussis/IPV(Vero)/HIB(PRP/T) Vaccine Powder and suspension for suspension for injection (lot UK110AA) (expiry date-31-Aug-2025) via intramuscular route in the left thigh as prophylactic vaccination (immunization) (latency-same day) and the HIB component was not reconstituted with the DTAP-IVP component with no reported adverse event (single component of a two-component product administered) Action taken: not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
More
|
||||||
| 2831062 | 0.17 | F | PA | 03/13/2025 |
DTAPIPVHIB |
SANOFI PASTEUR |
UK149AB |
No adverse event, Product preparation issue
No adverse event, Product preparation issue
|
inappropriate use due to the administration of the dtap-ipv liquid portion of pentacel with sterile ...
inappropriate use due to the administration of the dtap-ipv liquid portion of pentacel with sterile water. acthib was not administered to the patient with no reported ae; Initial information received on 11-Mar-2025 regarding an unsolicited valid non-serious case received from a other healthcare professional. This case involves a 2 months old female patient who had inappropriate use due to the administration of the DTAP-IPV liquid portion of diphtheria/tetanus/5 hybrid AC pertussis/IPV(VERO)/HIB(PRP/T) vaccine [Pentacel (vero)] with sterile water and ACTHIB was not administered to the patient with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included rotavirus vaccine, pneumococcal vaccine CONJ 20V (CRM197) (PREVNAR 20) and hepatitis B vaccine, all for Immunisation. On 14-Feb-2025 the patient developed a non-serious inappropriate use due to the administration of the DTAP-IPV liquid portion of standard dose of 0.5 ml of suspect diphtheria/tetanus/5 hybrid AC pertussis/IPV(VERO)/HIB(PRP/T) vaccine Suspension for injection once (Unknown strength) with lot UK149AB and expiry date 31-Aug-205 via intramuscular route in the right thigh for Immunization with sterile water. ACTHIB was not administered to the patient with no reported adverse event (single component of a two-component product administered) (Latency same day). Reportedly, This situation is pre-assessed as a medication error/an inappropriate use due to the administration of the DTAP-IPV liquid portion of pentacel with sterile water. ACTHIB was not administered to the patient. Medical Assistant reported that pentacel was diluted incorrectly and administered to a patient. The liquid portion (DTAP-IPV component) was mixed with another diluent (sterile water) and administered to a patient. The powder (ACTHIB) portion was not administered. Action taken was not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
More
|
||||||
| 2831063 | NY | 03/13/2025 |
HIBV |
SANOFI PASTEUR |
UJ995AA |
Expired product administered, No adverse event
Expired product administered, No adverse event
|
expired dose of ACT-HIB was given to a patient with no reported adverse event; Initial information r...
expired dose of ACT-HIB was given to a patient with no reported adverse event; Initial information received on 11-Mar-2025 regarding an unsolicited valid non-serious case received from a nurse. This case involves a patient of unknown gender and age who was inappropriately administered with an expired dose of HIB (PRP/T) Vaccine [ACT-HIB] with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 01-Mar-2025, the patient received an expired unknown dose of suspect HIB (PRP/T) Vaccine, Powder and solvent for solution for injection (lot UJ995AA, expiry date 28-Feb-2025; strength standard, Frequency = Once) via unknown route in unknown administration site for immunization, with no reported adverse event (expired product administered) (latency same day). Action taken was not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
More
|
||||||||
| 2831089 | 36 | F | AK | 03/13/2025 |
FLU3 |
SEQIRUS, INC. |
P100710103 |
Lymph node pain, Lymphadenopathy
Lymph node pain, Lymphadenopathy
|
According to the patient she has been experiencing swollen lymph nodes in neck, behind the ear and u...
According to the patient she has been experiencing swollen lymph nodes in neck, behind the ear and under arm on the left side. All tender to touch. Swelling lasting up to one week.
More
|
||||||
| 2831090 | 50 | F | MO | 03/13/2025 |
VARZOS VARZOS |
GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS |
|
Immediate post-injection reaction, Myalgia, Pain in extremity, Peripheral swelli...
Immediate post-injection reaction, Myalgia, Pain in extremity, Peripheral swelling, Pyrexia; Sleep disorder
More
|
Was given a shingles shot, Shingrix This med hurt immediately while giving My left arm hurt so bad I...
Was given a shingles shot, Shingrix This med hurt immediately while giving My left arm hurt so bad I couldn't sleep it hurt down to the muscle.. it was swollen about a quarter inch high and it was the size of a baseball around. This is March 6 and my muscle is still sore. I applied cold compresses and heat, the cold worked better. I was feverish and felt like someone had branded me
More
|
||||||
| 2831091 | 68 | F | IA | 03/13/2025 |
VARZOS |
GLAXOSMITHKLINE BIOLOGICALS |
|
Injection site pain, Injection site rash, Pruritus
Injection site pain, Injection site rash, Pruritus
|
Rash at site of Shingrex vaccination (first shot). Started day after shot, slightly larger the follo...
Rash at site of Shingrex vaccination (first shot). Started day after shot, slightly larger the following day and slightly itchy, mild pain at injection site. Using ice and 1% hydrocortisone.
More
|
||||||
| 2831092 | F | NY | 03/13/2025 |
PNC20 PNC20 |
PFIZER\WYETH PFIZER\WYETH |
|
Headache, Injected limb mobility decreased, Malaise, Pain, Pain in extremity; Te...
Headache, Injected limb mobility decreased, Malaise, Pain, Pain in extremity; Tenderness
More
|
Received Prevnar21 on 3/06/2025. That night my arm where I received the injection really started to ...
Received Prevnar21 on 3/06/2025. That night my arm where I received the injection really started to hurt. To the point that I could not move arm without significant pain. The next morning I started with body aches, headache and chills and over all not feeling well. Work up 3/8/3025 feeling a little better. Don't feel as chilled or feverish but still have headache and arm remains very tender, difficult to use arm where I received the injection.
More
|
|||||||
| 2831093 | 30 | M | MI | 03/13/2025 |
FLUX FLUX |
UNKNOWN MANUFACTURER UNKNOWN MANUFACTURER |
|
Asthenia, Chills, Gastrooesophageal reflux disease, Influenza like illness, Mala...
Asthenia, Chills, Gastrooesophageal reflux disease, Influenza like illness, Malaise; Nausea, Rash pruritic, Vomiting
More
|
Patient to ED by ambulance x 2 sick days with N/V, diarrhea, H/O diabetic gastroparesis(on Reglan), ...
Patient to ED by ambulance x 2 sick days with N/V, diarrhea, H/O diabetic gastroparesis(on Reglan), GERD, weakness, chills, thought it was a gallbladder attack. Spouse sick. Allergy to Flu Vaccine: rash. For flu like symptoms initiated Tamiflu 75mg however shortly afterwards the patient did break out in a pruritic rash, no throat closing sensation or angioedema. Administered Benadryl IV which resolved the rash. Product: Tamiflu 75mg capsule Event: Rash Patient also has allergy to flu vaccine.
More
|
||||||
| 2831094 | 65 | M | MA | 03/13/2025 |
COVID19 COVID19 COVID19 COVID19 |
PFIZER\BIONTECH PFIZER\BIONTECH PFIZER\BIONTECH PFIZER\BIONTECH |
er8737 er8737 ew0164 ew0164 |
Amnesia, Brain fog, Disturbance in attention, Fatigue, Gait disturbance; Hypoaes...
Amnesia, Brain fog, Disturbance in attention, Fatigue, Gait disturbance; Hypoaesthesia, Muscular weakness, Myalgia, Nervous system disorder, Paraesthesia; Amnesia, Brain fog, Disturbance in attention, Fatigue, Gait disturbance; Hypoaesthesia, Muscular weakness, Myalgia, Nervous system disorder, Paraesthesia
More
|
EXCESSIVE FATIQUE,WEAKNESS IN LEGS.COULD BARELY WALK .NEUROLOGICAL DISORDER.MUSCLE ACHES,TINGLING AN...
EXCESSIVE FATIQUE,WEAKNESS IN LEGS.COULD BARELY WALK .NEUROLOGICAL DISORDER.MUSCLE ACHES,TINGLING AND NUMBNESS,,,BRAIN FOG,, LOSS OF MEMORY ,DIFFICULTY CONCENTRATING AND FOCUSING, I COULD BARELY WALK FOR 3 YEARS,UNTIL I STARTED TAKING SPIKE PROTEIN DETOXIFICATION MED. DAILY SAUNAS , DOING A 3 DAY FAST ONCE A MONTH TO GET RID OF IGG4 ANTIBODIES I HAD TO INVESTIGATE WHAT DOCTORS IN (REDACTED) WERE DOING FOR THEIR PATIENTS.TO DETOXIFY SPIKE PROTEIN AND IGG4 ANTIBODIES
More
|
โ | โ | ||||
| 2831095 | 57 | M | CA | 03/13/2025 |
RSV |
PFIZER\WYETH |
LG9829 |
Device connection issue, Product preparation issue, Syringe issue
Device connection issue, Product preparation issue, Syringe issue
|
5-6 faulty RSV vaccines since we started administering them in the clinic. The lurelock on the kit f...
5-6 faulty RSV vaccines since we started administering them in the clinic. The lurelock on the kit falls off when attempting to attach to the vial adapter and does not attach to the syringe/diluent porting of the vaccine in order to mix the solution resulting in inadequate mixing of the RSV vaccine and leaking
More
|
||||||
| 2831096 | 16 | M | NM | 03/13/2025 |
MENB |
NOVARTIS VACCINES AND DIAGNOSTICS |
99G34 |
Syringe issue
Syringe issue
|
While I was trying to remove air from syringe of Men B vaccine Bexsero, the liquid kept seeping out ...
While I was trying to remove air from syringe of Men B vaccine Bexsero, the liquid kept seeping out of the syringe. It was not able to remove the air and was left with only half a dose of the vaccine. This vaccine was not given to this pt. and was report as wasted.
More
|
||||||
| 2831097 | MI | 03/13/2025 |
VARZOS |
GLAXOSMITHKLINE BIOLOGICALS |
KB2YT |
Liquid product physical issue
Liquid product physical issue
|
When Shingrix Lyophilized component was being reconstituted, a black particulate was noticed in the ...
When Shingrix Lyophilized component was being reconstituted, a black particulate was noticed in the vial. Vial was not used or administered on a patient, but segregated from inventory and a new vial was used.
More
|
||||||||
| 2831131 | 58 | M | TX | 03/13/2025 |
COVID19 FLU3 |
MODERNA GLAXOSMITHKLINE BIOLOGICALS |
|
Atrial fibrillation, Deep vein thrombosis, Pulmonary embolism; Atrial fibrillati...
Atrial fibrillation, Deep vein thrombosis, Pulmonary embolism; Atrial fibrillation, Deep vein thrombosis, Pulmonary embolism
More
|
the blood clot moved to my lungs becoming a pulmonary embolism (my heart also then went into Afib)/b...
the blood clot moved to my lungs becoming a pulmonary embolism (my heart also then went into Afib)/blood clot moved to my lungs becoming a pulmonary embolism (my heart also then went into Afib)/the blood clot moved to the lungs, resulting in a pulmo; the blood clot moved to my lungs becoming a pulmonary embolism (my heart also then went into Afib)/blood clot moved to my lungs becoming a pulmonary embolism (my heart also then went into Afib)/the blood clot moved to the lungs, resulting in a pulmon; I developed what turned out to be a DVT blood clot in my left calf/deep vein thrombosis (DVT) in the left calf/one week later, they developed a deep vein thrombosis (DVT) in the left calf; This spontaneous case was reported by a patient and describes the occurrence of PULMONARY EMBOLISM (the blood clot moved to my lungs becoming a pulmonary embolism (my heart also then went into Afib)/blood clot moved to my lungs becoming a pulmonary embolism (my heart also then went into Afib)/the blood clot moved to the lungs, resulting in a pulmo), DEEP VEIN THROMBOSIS (I developed what turned out to be a DVT blood clot in my left calf/deep vein thrombosis (DVT) in the left calf/one week later, they developed a deep vein thrombosis (DVT) in the left calf) and ATRIAL FIBRILLATION (the blood clot moved to my lungs becoming a pulmonary embolism (my heart also then went into Afib)/blood clot moved to my lungs becoming a pulmonary embolism (my heart also then went into Afib)/the blood clot moved to the lungs, resulting in a pulmon) in a 58-year-old male patient who received mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) for COVID-19 prophylaxis. Co-suspect product included non-company product Influenza vaccine inact split 3v (Fluarix) for an unknown indication. Previously administered products included for Product used for unknown indication: Pfizer BioNTech COVID-19 vaccine (Patient previously always had Pfizer). Past adverse reactions to the above products included No adverse effect with Pfizer BioNTech COVID-19 vaccine. Concomitant products included Docosahexaenoic acid, Eicosapentaenoic acid (Omega-3) for an unknown indication. On 15-Nov-2024, the patient received dose of mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) (Intramuscular use) 1 dosage form and dose of Influenza vaccine inact split 3v (Fluarix) (unknown route) 1 dosage form. In November 2024, the patient experienced DEEP VEIN THROMBOSIS (I developed what turned out to be a DVT blood clot in my left calf/deep vein thrombosis (DVT) in the left calf/one week later, they developed a deep vein thrombosis (DVT) in the left calf) (seriousness criteria hospitalization and medically significant). In January 2025, the patient experienced ATRIAL FIBRILLATION (the blood clot moved to my lungs becoming a pulmonary embolism (my heart also then went into Afib)/blood clot moved to my lungs becoming a pulmonary embolism (my heart also then went into Afib)/the blood clot moved to the lungs, resulting in a pulmon) (seriousness criteria hospitalization and medically significant). On 17-Jan-2025, after starting mRNA-1273.712 (SPIKEVAX 2024-2025 PFS), the patient experienced PULMONARY EMBOLISM (the blood clot moved to my lungs becoming a pulmonary embolism (my heart also then went into Afib)/blood clot moved to my lungs becoming a pulmonary embolism (my heart also then went into Afib)/the blood clot moved to the lungs, resulting in a pulmo) (seriousness criteria hospitalization and medically significant). The patient was hospitalized from 22-Jan-2025 to 27-Jan-2025 due to ATRIAL FIBRILLATION, DEEP VEIN THROMBOSIS and PULMONARY EMBOLISM. At the time of the report, PULMONARY EMBOLISM (the blood clot moved to my lungs becoming a pulmonary embolism (my heart also then went into Afib)/blood clot moved to my lungs becoming a pulmonary embolism (my heart also then went into Afib)/the blood clot moved to the lungs, resulting in a pulmo), DEEP VEIN THROMBOSIS (I developed what turned out to be a DVT blood clot in my left calf/deep vein thrombosis (DVT) in the left calf/one week later, they developed a deep vein thrombosis (DVT) in the left calf) and ATRIAL FIBRILLATION (the blood clot moved to my lungs becoming a pulmonary embolism (my heart also then went into Afib)/blood clot moved to my lungs becoming a pulmonary embolism (my heart also then went into Afib)/the blood clot moved to the lungs, resulting in a pulmon) had not resolved. Patient was not allergic to any medications, food or other products. Patient treatment medication included M.E.E.S 50 plus once a day for product used for unknown indication. Patient was first time received Moderna Covid-19 vaccination as booter dose. Approximately one-week later post vaccination patient was developed a deep vein thrombosis (DVT) in the left calf. In January, the blood clot was moved to the lungs for patient, which caused a pulmonary embolism and atrial fibrillation for patient. Patient was developed a pulmonary embolism on 17-Jan-2025 in AM. Patient was hospitalized for five days from 22-Jan-2025 to 27-Jan-2025 and he went through a catheter-based clot removal, and since then patient was on unspecified blood thinners and beta blocker as a treatment medication. Due to symptom patient wear compression socks. Reporter was stated that blood clot and Covid booster felt like the only possibility as a cause. A hematology consultation was scheduled for further evaluation for patient. Most recent FOLLOW-UP information incorporated above includes: On 18-Feb-2025: Live Significant follow up added in which country of incident, Country in which Event Occurred, suspect drug coding, co-suspect drug coding, reported reaction, Reporter causality was updated. New reference number was added. On 18-Feb-2025: Live non-significant follow up was received and new reference number was added. On 27-Feb-2025: Significant follow-up received in which primary reporter detail was updated, and secondary reporter detail was added, patient demography was updated (Patient initial, age, height, weight, race, ethnic group, Suspect and co-suspect product vaccination site of administration was added, new concomitant medication was added nature made omega 3 and M.E.E.S 50 plus. Event outcome for the event of Deep vein thrombosis Atrial fibrillation and Pulmonary embolism was updated. For all the reported event seriousness was updated as Hospitalized and Medically Significant. Event onset date for the event Pulmonary embolism and Atrial fibrillation was updated. Case narrative was updated. On 28-Feb-2025: Live non-significant follow-up received in which other manufacturer Reference number was added.; Reporter's Comments: Concomitant Fluarix remains as a confounder. The benefit-risk relationship of mRNA-1273 (Spikevax) vaccine is not affected by this report.
More
|
โ | |||||
| 2831173 | 52 | F | MI | 03/13/2025 |
VARZOS VARZOS |
GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS |
|
Injected limb mobility decreased, Nerve conduction studies, Pain, Pain in extrem...
Injected limb mobility decreased, Nerve conduction studies, Pain, Pain in extremity, Ultrasound scan; X-ray
More
|
pain in left arm , sharp shooting pain down arm. unable to use arm like before. being continually ...
pain in left arm , sharp shooting pain down arm. unable to use arm like before. being continually getting worse.
More
|
||||||
| 2831174 | 0.17 | M | AR | 03/13/2025 |
DTPPVHBHPB PNC15 RV1 |
MSP VACCINE COMPANY MERCK & CO. INC. GLAXOSMITHKLINE BIOLOGICALS |
U7921AA Y005351 HP495 |
Extra dose administered; Extra dose administered; Extra dose administered
Extra dose administered; Extra dose administered; Extra dose administered
|
Patient had 2 vaccine records in our IIS, they each had different last names and different spelling ...
Patient had 2 vaccine records in our IIS, they each had different last names and different spelling of first name. Patient then received a second dose of RSV Beyfortus in error. First dose given on 01/31/2025 and second dose given on 03/11/2025.
More
|
||||||
| 2831175 | 0.5 | F | MI | 03/13/2025 |
DTAPIPVHIB HEP PNC20 RV5 |
SANOFI PASTEUR GLAXOSMITHKLINE BIOLOGICALS PFIZER\WYETH MERCK & CO. INC. |
UK149AB LG749 LX2497 Y014317 |
Contraindication to vaccination, No adverse event; Contraindication to vaccinati...
Contraindication to vaccination, No adverse event; Contraindication to vaccination, No adverse event; Contraindication to vaccination, No adverse event; Contraindication to vaccination, No adverse event
More
|
NO ADVERSE EVENT OCCURRED. DUE TO THE PATIENT'S HEALTH HISTORY, IT WAS MEDICALLY CONTRAINDICATE...
NO ADVERSE EVENT OCCURRED. DUE TO THE PATIENT'S HEALTH HISTORY, IT WAS MEDICALLY CONTRAINDICATED THAT THE PATIENT RECEIVE THE ROTAVIRUS VACCINE.
More
|
||||||
| 2831176 | 4 | F | LA | 03/13/2025 |
MMRV |
MERCK & CO. INC. |
Y018154 |
Injection site erythema
Injection site erythema
|
patient developed redness around the injection site one day after the injection was given. MD exami...
patient developed redness around the injection site one day after the injection was given. MD examined the patient and prescribed Prednisolone.
More
|
||||||
| 2831177 | 0.25 | M | TN | 03/13/2025 |
DTAPHEPBIP HIBV PNC20 RV1 |
GLAXOSMITHKLINE BIOLOGICALS MERCK & CO. INC. PFIZER\WYETH GLAXOSMITHKLINE BIOLOGICALS |
D252F Y00000000000000 LJ5282 5N2AN |
Extra dose administered, No adverse event; Extra dose administered, No adverse e...
Extra dose administered, No adverse event; Extra dose administered, No adverse event; Extra dose administered, No adverse event; Extra dose administered, No adverse event
More
|
No noted or reported adverse events thus far
No noted or reported adverse events thus far
|
||||||
| 2831178 | 69 | F | MI | 03/13/2025 |
COVID19 COVID19 |
PFIZER\BIONTECH PFIZER\BIONTECH |
LP1776 LP1776 |
Arthralgia, Chills, Condition aggravated, Fibromyalgia, Joint swelling; Migraine...
Arthralgia, Chills, Condition aggravated, Fibromyalgia, Joint swelling; Migraine, Nausea, Pain, Pyrexia
More
|
Side effects: Fever lasting 5 days, peaking at 101.3, chills, very bad body aches, joint pain/swelli...
Side effects: Fever lasting 5 days, peaking at 101.3, chills, very bad body aches, joint pain/swelling(Fingers so swollen I could not make a fist.) Nausea, Headache causing a series of migraines. All triggering a new fibromyalgia flare.
More
|
||||||
| 2831179 | 3 | F | MI | 03/13/2025 |
FLU3 |
SANOFI PASTEUR |
U8465CA |
Extra dose administered
Extra dose administered
|
Extra dose given. Patient get Influenza vaccine on 10-16-2024, did not need second dose for this se...
Extra dose given. Patient get Influenza vaccine on 10-16-2024, did not need second dose for this season.
More
|
||||||
| 2831180 | 33 | F | FL | 03/13/2025 |
COVID19 |
PFIZER\BIONTECH |
EW0161 |
Anti-thyroid antibody increased, Blood thyroid stimulating hormone increased
Anti-thyroid antibody increased, Blood thyroid stimulating hormone increased
|
Lab results of TSH 8.4c and Thyroid Peroxidase Antibodies 462.
Lab results of TSH 8.4c and Thyroid Peroxidase Antibodies 462.
|
||||||
| 2831181 | 80 | F | TN | 03/13/2025 |
RSV |
GLAXOSMITHKLINE BIOLOGICALS |
unknown |
Condition aggravated, Cough, Dyspnoea
Condition aggravated, Cough, Dyspnoea
|
Re-exacerbation of her chronic cough and shortness of breath
Re-exacerbation of her chronic cough and shortness of breath
|
||||||
| 2831182 | 61 | F | AL | 03/13/2025 |
COVID19 COVID19 |
MODERNA MODERNA |
023M20A 003B21A |
Chemotherapy, Endometrial cancer, Hysterectomy; Chemotherapy, Endometrial cancer...
Chemotherapy, Endometrial cancer, Hysterectomy; Chemotherapy, Endometrial cancer, Hysterectomy
More
|
Patient was diagnosed with endometrial cancer on 8/11/21. She had a complete hysterectomy and 6 rou...
Patient was diagnosed with endometrial cancer on 8/11/21. She had a complete hysterectomy and 6 rounds of chemotherapy. She is currently cancer free.
More
|
||||||
| 2831183 | 64 | F | IN | 03/13/2025 |
COVID19 FLU3 |
UNKNOWN MANUFACTURER SEQIRUS, INC. |
|
Chest pain, Dyspnoea, Palpitations; Chest pain, Dyspnoea, Palpitations
Chest pain, Dyspnoea, Palpitations; Chest pain, Dyspnoea, Palpitations
|
pt says after getting the vaccines she came home and within an hour her heart started thumping and s...
pt says after getting the vaccines she came home and within an hour her heart started thumping and she began having chest pains. She felt as if she couldn't breath. She thought she was having a heart attack so she used her inhaler. This helped her breath and calmed her down. She was scared and thought she was going to die. She went to bed and stayed there that night and the next day. She feels as is if it is an allergic reaction from the vaccine so will not be taking any more. She contacted her pharmacy and was told it maybe the norovirus that caused her to feel this way. She went to her physicians office and was told it was from the covid vaccine. She was given steroids and refilled albuterol. She continues to have breathing issues.
More
|
โ | |||||
| 2831184 | 54 | M | CA | 03/13/2025 |
TDAP |
SANOFI PASTEUR |
U8352AA |
Arthralgia, Joint range of motion decreased, Mobility decreased, Muscle spasms
Arthralgia, Joint range of motion decreased, Mobility decreased, Muscle spasms
|
Member reports pain in shoulder since last vaccine. Member reports pain has been constant since that...
Member reports pain in shoulder since last vaccine. Member reports pain has been constant since that appt. ROM is limited at times. And at random times he has spasms and pain. Some times he cannot lift his groceries or rise his hand above his head
More
|
||||||
| 2831186 | 11 | F | FL | 03/13/2025 |
DTAP |
SANOFI PASTEUR |
|
Erythema, Pain in extremity, Peripheral swelling, Pruritus
Erythema, Pain in extremity, Peripheral swelling, Pruritus
|
Left arm sore, red, swollen, painful, itchy
Left arm sore, red, swollen, painful, itchy
|
||||||
| 2831187 | 67 | F | IA | 03/13/2025 |
RSV RSV RSV RSV |
PFIZER\WYETH PFIZER\WYETH PFIZER\WYETH PFIZER\WYETH |
LG9829 LG9829 LG9829 LG9829 |
Abdominal pain upper, Diarrhoea, Dizziness, Dysstasia, Nausea; Diarrhoea, Dizzin...
Abdominal pain upper, Diarrhoea, Dizziness, Dysstasia, Nausea; Diarrhoea, Dizziness, Muscle spasms, Nausea; Abdominal pain upper, Diarrhoea, Dizziness, Dysstasia, Nausea; Diarrhoea, Dizziness, Muscle spasms, Nausea
More
|
Extreme dizziness - couldn't stand up w/o feeling like I was going to pass out. Nausea, diarrh...
Extreme dizziness - couldn't stand up w/o feeling like I was going to pass out. Nausea, diarrhea, stomach cramps. Dizziness and diarrhea continued the next day. Shot was on Tuesday and symptoms continued thru Wednesday.
More
|
||||||
| 2831189 | 78 | F | RI | 03/13/2025 |
VARZOS |
GLAXOSMITHKLINE BIOLOGICALS |
3X97J |
Dyspnoea, Vision blurred
Dyspnoea, Vision blurred
|
PATIENT CLAIMS SHE HAD BLURRED VISION AND CONSTRICTED BREATHING FOR 36 HOURS AFTER VACCINE. SHE DID ...
PATIENT CLAIMS SHE HAD BLURRED VISION AND CONSTRICTED BREATHING FOR 36 HOURS AFTER VACCINE. SHE DID NOT REPORT TO ANY MEDICAL PROFESSIONAL
More
|
||||||
| 2831190 | 3 | F | MD | 03/13/2025 |
TDAP |
GLAXOSMITHKLINE BIOLOGICALS |
|
Wrong product administered
Wrong product administered
|
Patient mistakenly received the Tdap vaccine instead of the ordered Dtap.
Patient mistakenly received the Tdap vaccine instead of the ordered Dtap.
|
||||||
| 2831191 | 56 | M | NY | 03/13/2025 |
HPV9 HPV9 HPV9 HPV9 |
MERCK & CO. INC. MERCK & CO. INC. MERCK & CO. INC. MERCK & CO. INC. |
Y013469 Y013469 Y013469 Y013469 |
Arthralgia, Balance disorder, Body temperature decreased, Dizziness, Eye irritat...
Arthralgia, Balance disorder, Body temperature decreased, Dizziness, Eye irritation; Eye pruritus, Headache, Inflammation, Loss of control of legs, Muscular weakness; Ocular discomfort, Oropharyngeal pain, Pharyngeal swelling, Pyrexia, Tenderness; Vision blurred
More
|
I noticed first i was a little dizzy and i had some balance issues, I would be walking and this was ...
I noticed first i was a little dizzy and i had some balance issues, I would be walking and this was around 10 and i was walking back from the store. And it was bad enough that for a couple mins i had to rest against the wall. The dizziness was in my head but the balance issues was like i wasn't able to control my legs very well. In additional i started having a itchy and burning issues in my eyes and my vision got blurry, and there is a lot of pressure, and they have kept going off and on since then. After 1 am i started having a really bad headache and its not responding to meds, I also have had a swollen and sore throat. The balance issues they have manifested i could be standing somewhere and then my body doesn't wanna continue standing. and my legs just weak, My body temp is low and i am now running a low grade fever. and nothing has been helping bring that down. Inflammation and pain for joint pain. Tenderness on whole body.
More
|
||||||
| 2831192 | 57 | F | PA | 03/13/2025 |
UNK UNK UNK |
UNKNOWN MANUFACTURER UNKNOWN MANUFACTURER UNKNOWN MANUFACTURER |
|
Arthralgia, Back pain, Blister, Burning sensation, Cerebrovascular accident; Lab...
Arthralgia, Back pain, Blister, Burning sensation, Cerebrovascular accident; Laboratory test, Nausea, Oesophagogastroduodenoscopy, Pain in extremity, Rash; Rash pruritic
More
|
pt says she became nauseated and her arm and shoulder area hurt really bad. About a month after tha...
pt says she became nauseated and her arm and shoulder area hurt really bad. About a month after that she was hospitalized for a stroke. She was in Hospital (10 days) and then transferred to another hospital (10 days) and then to rehab (1 month) rehab center . She then moved and after a couple of months. She noticed that her body was changing. She then developed blisters and rash on her buttocks and between her legs. She was itching and scratching it. It cleared up eventually. She has pain and burning within the body in her hand, shoulder, back, arm and legs that will not go away. She was given cream meds and pain medication for it but it doesn't help much. She was told to follow up with her doctor and she is going to ask for a specialist.
More
|
โ | โ |